Home Contact Center Add this

GenePOC Inc.

Bringing the lab to the patient

GenePOC Inc. develops affordable, rapid molecular tests to identify infectious agents in point-of-care settings. Its mission is to empower healthcare professionals and patients with affordable, simple, and rapid Point of Care (POC) molecular diagnostic tests for infectious diseases.

Current Distributors

  • Astra Formedic S.r.l.
    • Italy
  • bestbion dx GmbH
    • Austria
    • Germany
  • Biosynex Group
    • France
  • EMM Life Science AB
    • Sweden
    • Denmark
    • Finland
    • Iceland
    • Norway
  • Fannin Ltd
    • Ireland
  • Mediphos Group BV
    • Belgium
    • Luxembourg
    • Netherlands
  • Near Patient Diagnostics Ltd
    • United Kingdom
  • Vitro SA
    • Spain
    • Portugal
  • Sedeer Medical
    • United Arab Emirates
    • Bahrain
    • Kuwait
    • Oman
  • BÜHLMANN Laboratories AG
    • Switzerland
  • Distributor negotiations ongoing
    • Canada
    • USA

 

Patrice Allibert

Patrice Allibert

Chief Executive Officer, GenePOC Inc.

Dr Allibert obtained his Ph.D. in Molecular Biology from the University of Grenoble (France) in 1986. He has over 30 years of experience in product development, manufacturing and commercialization with major biomedical industries in the USA, Europe, and Canada. Patrice started working at bioMérieux (France) where he launched the first HLA-DR test based on molecular methods for bone marrow and graft transplantation. He then held multiple management positions in diagnostics and R&D, has acted as an expert for the European Community and as a member of the Institute Advisory Board of the CHIR Institute of Infection and Immunity. He joined GenePOC Inc. in 2012 as CEO.

GenePOC Inc.

360 rue Franquet, porte 3
G1P 4N3 Québec
Canada

Tel. 1 418 650-3535